SKUTNIK et al. V. HASHIMOTO et al. - Page 2





      Interference No. 103,224                                                                           

                               FINAL DECISION UNDER 37 CFR § 1.658 (a)                                   
           This interference involves an application of the junior party, Skutnik et al                  
      (Skutnik), and a patent of the senior party, Hashimoto et al (Hashimoto).                          
           According to the record before us, the involved Skutnik application is assigned to            
      Ensign-Bickford Optics Company; whereas the involved Hashimoto patent is owned by co-              
      assignees Dainippon Ink and Chemicals, Inc. and Yamamura Glass Co., Ltd.                           
           The subject matter involved in this interference relates to a method of increasing            
      the strength of a glass container essentially by applying a coating of a silane coupling           
      agent and a reactive compound to the surface of the glass container, and then curing the           
      coating. The method is more particularly defined by the sole count in this interference as         
      follows:                                                                                           
      Count 1                                                                                            
           A method of increasing the strength of a glass container which consists essentially           
      of applying a coating material consisting essentially of a silane coupling agent and a             
      reactive compound having at least two (meth) acrylol groups in the molecule to the surface         
      of the glass article, and then subjecting the coated glass container to energy to cure the         
      coating.                                                                                           
           The claims of the parties which correspond to this count are:                                 
      Skutnik et al.:                Claims 39-42                                                        
      Hashimoto et al.:              Claims 1-15                                                         
                                                   2                                                     
















Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007